Financials Artemis Medicare Services Limited
Equities
ARTEMISMED
INE025R01021
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
178.5 INR | +0.82% |
|
+0.12% | -0.89% |
Valuation
Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 9,107 | 24,445 | - | - |
Enterprise Value (EV) 1 | 9,107 | 23,076 | 24,445 | 24,445 |
P/E ratio | 24.3 x | 48.1 x | 28.8 x | 18.2 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | 2.63 x | - | - |
EV / Revenue | - | 2.63 x | - | - |
EV / EBITDA | - | 22.8 x | - | - |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | 5.27 x | - | - |
Nbr of stocks (in thousands) | 134,119 | 136,916 | - | - |
Reference price 2 | 67.90 | 178.5 | 178.5 | 178.5 |
Announcement Date | 5/5/23 | 5/10/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net sales 1 | - | 8,786 | - | - |
EBITDA 1 | - | 1,011 | - | - |
EBIT | - | - | - | - |
Operating Margin | - | - | - | - |
Earnings before Tax (EBT) 1 | - | 684.5 | - | - |
Net income 1 | 386 | 491.4 | - | - |
Net margin | - | 5.59% | - | - |
EPS 2 | 2.790 | 3.530 | 6.200 | 9.800 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 5/5/23 | 5/10/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2024 Q3 | 2024 Q4 |
---|---|---|
Net sales 1 | 2,340 | 2,440 |
EBITDA | - | - |
EBIT | - | - |
Operating Margin | - | - |
Earnings before Tax (EBT) | - | - |
Net income | - | 496 |
Net margin | - | 20.33% |
EPS | - | - |
Dividend per Share | - | - |
Announcement Date | - | - |
Balance Sheet Analysis
Fiscal Period: March | 2023 | 2024 |
---|---|---|
Net Debt | - | - |
Net Cash position | - | - |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | - |
ROE (net income / shareholders' equity) | - | 11.5% |
ROA (Net income/ Total Assets) | - | - |
Assets 1 | - | - |
Book Value Per Share 2 | - | 32.20 |
Cash Flow per Share | - | - |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 5/5/23 | 5/10/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.89% | 291M | |
-32.30% | 13.37B | |
+3.98% | 11.75B | |
-3.60% | 11.57B | |
+7.59% | 10.85B | |
+26.23% | 8.55B | |
-11.44% | 7.24B | |
+7.82% | 6.84B | |
+8.77% | 6.5B | |
0.00% | 4.4B |
- Stock Market
- Equities
- ARTEMISMED Stock
- Financials Artemis Medicare Services Limited